Firstly, we analyzed effects of the IDO1 modulator 1-methyl-D-tryptophan (1MT) on tumor cell engraftment and leukemia development, whereby we started to treat the mice with 1MT on the same day they were transplanted with the tumor cells. This evidence concerns the gene IDO1 and leukemia.